• argenx announces positive CHMP opinion for subcutaneous efgartigimod for generalized myasthenia gravis

    Friday September 15th 2023

  • New study discovers how neurons die in Alzheimer’s disease

    Friday September 15th 2023

  • Augustine Therapeutics expands its leadership team and R&D platform, enters regulatory development

    Tuesday September 12th 2023

  • SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV

    Friday September 8th 2023

  • The QbD Group acquires life sciences consultancy Azierta to reinforce its global vigilance services and expand its presence in Spain

    Tuesday September 5th 2023

  • SwiftPharma and AntoXa Corporation sign exclusive collaboration agreement to support the development and commercialization of a plant-made antibody against ricin exposure

    Friday September 1st 2023

  • FOx BIOSYSTEMS appoints Dr. Mark Truesdale as CEO

    Friday September 1st 2023

  • Belgians send miniature heart into space for ageing research

    Wednesday August 30th 2023

  • Your news here?

  • Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus

    Tuesday August 29th 2023

  • AI assists in arthritis diagnosis based on MRI images

    Monday August 28th 2023

  • ViroVet achieves groundbreaking results with antiviral drug against BVD

    Monday August 28th 2023

Strategic Partners